Pi Pharma Intelligence selects Capifly as a Venture Debt
CollaborationsPi Pharma intelligence have selected Capifly, a provider of quick and non-dilutive capital, against annual recurring revenue for growing technology companies, the two companies will work on different financial transactions during the coming period
.jpg)
Pi Pharma Intelligence Joins Second Cohort of SURGE for Enhanced Growth and Potential
Nov, 2021
Pi Pharma Joins Second Cohort of SURGE for Enhanced Growth and Potential
Pi Pharma Intelligence has been recognized as one of the Top 10 Pioneers in Pharma Pre-Marketing insights
Oct, 2024
We are thrilled to announce that Pi Pharma Intelligence has been recognized as one of the Top 10 Pioneers in Pharma Pre-Marketing insights across the Middle East by Insights Success Global for February 2024
Pi Pharma Intelligence Have Participated in The Investor Readiness Program as Part From SURGE Program.
Jun, 2023
Pi Pharma Intelligence Have Participated in The Investor Readiness Program as Part From SURGE Program.